Aura Biosciences (AURA) Total Current Liabilities (2020 - 2026)
Aura Biosciences (AURA) posted Total Current Liabilities of $16.7 million for Q1 2026, down 9.12% on a QoQ basis from $18.4 million in Q4 2025, and up 37.35% year-over-year from $12.2 million in Q1 2025.
Aura Biosciences (AURA) Total Current Liabilities (2020 - 2026) Analysis & Trends
Aura Biosciences' Total Current Liabilities history runs 7 years deep, the most recent figure standing at $16.7 million for Q1 2026.
- Quarterly Total Current Liabilities rose 37.35% year-over-year to $16.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.7 million (up 37.35% YoY) and the FY2025 annual result came in at $18.4 million, up 23.27% from the prior year.
- Total Current Liabilities was $16.7 million for Q1 2026 at Aura Biosciences, down from $18.4 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $18.8 million in Q3 2025 and bottomed at $5.0 million in Q1 2022.
- A 5-year average of $11.9 million and a median of $10.9 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities soared 70.88% — and 2023, when it climbed 9.33%.
- Aura Biosciences' Total Current Liabilities stood at $10.5 million in 2022, then advanced by 18.17% to $12.4 million in 2023, then climbed by 20.68% to $14.9 million in 2024, then increased by 23.27% to $18.4 million in 2025, then retreated by 9.12% to $16.7 million in 2026.
- Business Quant data shows AURA's Total Current Liabilities at $16.7 million in Q1 2026, $18.4 million in Q4 2025, and $18.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Aura Biosciences | 485.62 Mn | 400.83 Mn | - | 16.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.71 Mn |
| Dec 31, 2025 | 18.38 Mn |
| Sep 30, 2025 | 18.82 Mn |
| Jun 30, 2025 | 14.85 Mn |
| Mar 31, 2025 | 12.16 Mn |
| Dec 31, 2024 | 14.91 Mn |
| Sep 30, 2024 | 14.71 Mn |
| Jun 30, 2024 | 10.55 Mn |
| Mar 31, 2024 | 9.66 Mn |
| Dec 31, 2023 | 12.36 Mn |
| Sep 30, 2023 | 10.89 Mn |
| Jun 30, 2023 | 8.90 Mn |
| Mar 31, 2023 | 8.11 Mn |
| Dec 31, 2022 | 10.46 Mn |
| Sep 30, 2022 | 9.96 Mn |
| Jun 30, 2022 | 5.81 Mn |
| Mar 31, 2022 | 5.00 Mn |
| Dec 31, 2021 | 7.36 Mn |
| Sep 30, 2021 | 5.83 Mn |
| Dec 31, 2020 | 2.66 Mn |